0000884300-13-000002.txt : 20130201
0000884300-13-000002.hdr.sgml : 20130201
20130201153451
ACCESSION NUMBER: 0000884300-13-000002
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20130201
DATE AS OF CHANGE: 20130201
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Venaxis, Inc.
CENTRAL INDEX KEY: 0001167419
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 841553387
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-79102
FILM NUMBER: 13566585
BUSINESS ADDRESS:
STREET 1: 1585 S. PERRY STREET
CITY: CASTLE ROCK
STATE: CO
ZIP: 80104
BUSINESS PHONE: (303) 794-2000
MAIL ADDRESS:
STREET 1: 1585 S. PERRY STREET
CITY: CASTLE ROCK
STATE: CO
ZIP: 80104
FORMER COMPANY:
FORMER CONFORMED NAME: AspenBio Pharma, Inc.
DATE OF NAME CHANGE: 20051110
FORMER COMPANY:
FORMER CONFORMED NAME: ASPENBIO INC
DATE OF NAME CHANGE: 20020213
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: PERKINS CAPITAL MANAGEMENT INC
CENTRAL INDEX KEY: 0000884300
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000]
IRS NUMBER: 411501962
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 730 EAST LAKE STREET
CITY: WAYZATA
STATE: MN
ZIP: 55391-1769
BUSINESS PHONE: 9524738367
MAIL ADDRESS:
STREET 1: 730 EAST LAKE STREET
CITY: WAYZATA
STATE: MN
ZIP: 55391
FORMER COMPANY:
FORMER CONFORMED NAME: PERKINS CAPITAL MANAGEMENT INC ET AL
DATE OF NAME CHANGE: 19960212
SC 13G/A
1
appyye1213ga.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 4)
AspenBio Pharma, Inc.
(Name of Issuer)
Common
(Title of Class of Securities)
045346301
(CUSIP Number)
December 31, 2012
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
/X/ Rule 13d-1(b)
/ / Rule 13d-1(c)
/ / Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form
displays a currently valid OMB control number.
CUSIP No. 045346301 Page 2
____________________________________________________________________
1.Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Perkins Capital Management, Inc.
41-1521690
____________________________________________________________________
2.Check the Appropriate Box if a Member of a Group (See Instructions)
(a) / /
(b) / /
____________________________________________________________________
3.SEC Use Only
____________________________________________________________________
4.Citizenship or Place of Organization
A Minnesota Corporation
____________________________________________________________________
Number of 5.Sole Voting Power
Shares Bene- 626,406
____________________________________________________
ficially owned 6.Shared Voting Power
by Each 0
____________________________________________________
7.Sole Dispositive Power
Reporting
717,873
____________________________________________________
Person With: 8.Shared Dispositive Power
0
____________________________________________________________________
9.Aggregate Amount Beneficially Owned by Each Reporting Person
717,813
____________________________________________________________________
10.Check if the Aggregate Amount in Row 9 Excludes Certain Shares
(See Instructions)
____________________________________________________________________
11.Percent of Class Represented by Amount in Row 9
9.3%
____________________________________________________________________
12.Type of Reporting Person (See Instructions)
IA
____________________________________________________________________
Item 1.
(a)Name of Issuer
AspenBio Pharma, Inc.
(b)Address of Issuer's Principal Executive Offices
1585 S. Perry St., Castle Rock, CO 80104
Item 2.
(a)Name of Person Filing
Perkins Capital Management, Inc.
(b)Address of Principal Business Office or, if none, Residence
730 Lake St. E., Wayzata, MN 55391
(c)Citizenship
A Minnesota Corporation and a U.S. Citizen
(d)Title of Class of Securities
Common
(e)CUSIP Number
045346301
Item 3. If this statement is filed pursuant to s240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
(a) / / Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o).
(b) / / Bank as defined in section 3(s)(6) of the Act
(15 U.S.C. 78c).
(c) / / Insurance Company as defined in section 3(a)(19) of the
Act (15 U.S.C. 78c).
(d) / / Investment Company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) /X/ An investment adviser in accordance with
s240.13d-1(b)(1)(ii)(E);
(f) / / An employee benefit plan or endowment fund in accordance
with s240.13d-1(b)(1)(ii)(F);
(g) / / A parent holding company or control person in accordance
with s240.13d-1(b)(ii)(G);
(h) / / A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) / / A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3);
(j) / / Group, in accordance with s240.13d-1(b)(1)(ii)(J).
Item 4. Ownership
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer identified
in Item 1.
(a) Amount Beneficially Owned:
717,873
(b) Percent of Class:
9.3%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
626,406
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
717,873
(iv) Shared power to dispose or to direct the disposition of:
0
Instruction: For computations regarding securities which represent
a right to acquire an underlying security see s240.13d(1).
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that
as of the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of securities,
check the following / /.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
N/A
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company
N/A
Item 8. Identification and Classification of Members of the Group
N/A
Item 9. Notice of Dissolution of Group
N/A
Item 10. Certification
(a) The following certification shall be included if the statement
is filed pursuant to s240.13d-1(b):
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired and are held in the
ordinary course of business and were not acquired and are not held for
the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true,
complete and correct.
Date: February 1, 2013
/s/ Richard C. Perkins
_________________________
Signature
Richard C. Perkins
EVP/Portfolio Manager
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001)